期刊文献+

体外肝细胞培养及在药物筛选中的应用 被引量:2

In vitro Hepatocyte Culture and Application for Drug Screening
下载PDF
导出
摘要 肝脏是人体内最复杂的器官之一,负责执行多种功能,是药物毒性检测的重要靶器官。体外培养肝细胞是进行药物毒性检测的重要途径。传统的体外培养主要是让细胞在不同成分的培养基中生长,或将细胞接种于主要由体内ECM成分如胶原或基质胶组成的基底上成层生长,但易快速丧失肝特异性功能。为解决此问题,学者们研究设计了多种能更好地模拟肝脏体内微环境特征的精加工技术,以进行肝脏细胞的体外培养。在三维支架上培养肝细胞,如球状聚集体和细胞片层,可促进细胞-细胞以及细胞-基质间的相互作用和肝细胞分化,维持肝细胞特异性功能,并形成类似体内的结构。最近,脱细胞基质已被用作支持理想的细胞-基质相互作用的细胞培养支架。本文就体外二维和应用球状聚集体、细胞片层、脱细胞基质进行三维培养肝细胞的具体技术进行了综述,并简要介绍其在药物筛选中的应用。 The liver is one of the most complex organs in the body, performs a multitude of functions, and is the important target organ for drug toxicity testing. To establish in vitro hepatic models is important ways for drug toxicity testing. Conventionally, in vitro cell culture has involved growing cells in different media compositions or layering them on matrices largely composed of natural ECM components such as collagen or matrigel. However the hepatic function is likely to be decreased or lost. Kinds of more sophisticated techniques applied in hepatocyte culture are being derived that have better capture distinct features of the liver in the in vivo microenvironmcnt. Three-dimensional (3D) cultures of liver cells in 3D scaffolds, as spheroids or cell sheets, allow for a high degree of cell-cell and cell-matrix interaction, differentiation, better liver function and an in vivo-like architecture. More recently, decellularized matrices have been used as scaffolds that support ideal cell-matrix interactions. In this review, we discussed the various configurations including 2D and 3D as spheroids, cell sheets and decellularized matriees that have been implemented in the in vitro culture of liver cells and their application in tools for drug screening.
出处 《中国生物医学工程学报》 CAS CSCD 北大核心 2015年第1期91-98,共8页 Chinese Journal of Biomedical Engineering
关键词 体外肝脏模型 细胞培养 药物毒性检测 in vitro liver models cell culture drug toxicity testing
  • 相关文献

参考文献55

  • 1Gomez- Lech6n M J, Castell JV, Donato MT, et al. Hepatocytes-the choice to investigate drug metabolism and toxicity in man : variability as a reflection of in vivo [ J ]. Chem Biol Interact, 2007, 168 ( 1 ) : 30 - 50. 被引量:1
  • 2GuiUouzo A and Gugucn-GuiUouzo C. Evolving concepts in liver tissue modeling and implications for in vitro toxicology [ J ]. Expert Opin Drug Metab Toxicol, 2008, 4(10) : 1279 - 1294. 被引量:1
  • 3Fraczek J, Bolleyn J, Vanhaecke T, et al. Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies [ J ]. Arch Toxicol, 2013, 87(4) : 577 -610. 被引量:1
  • 4Sakai Y, Huang HY, Hanada S, et al. Toward engineering of vascularized three-dimensional liver tissue equivalents possessing a clinically significant mass [ J ]. Biochemical Engineering Journal, 2010, 48(3) : 348 -361. 被引量:1
  • 5Wong SF, No DY, Choi YY, et al.Concave microwell based size-controllable hepatosphere as a three-dimensional liver tissue model [ J]. Biomaterials, 2011, 32 (32) : 8087 - 8096. 被引量:1
  • 6LeCluyse EL, Witek RP, Andersen ME, et al. Organotypic liver culture models: meeting current challenges in toxicity testing [J]. Cfit Rev Toxicol, 2012, 42(6) : 501 -548. 被引量:1
  • 7Domansky K, Inman W, Serdy J, et al. Perfused multiwell plate for 3 - D liver tissue engineering [J]. Lab Chip, 2010, 10( 1 ) : 51 -58. 被引量:1
  • 8Damania A, Jain E, Kumar A. Advancements in in vitro hepatic models: application for drug screening and therapeutics [ J ]. Hepatol Int, 2014, 8 ( 1 ) :23 - 38. 被引量:1
  • 9李洋,蔡双明,张莉莉,李旭.大鼠原代肝细胞、星状细胞、枯否细胞和肝窦内皮细胞的同步分离与培养[J].南方医科大学学报,2014,34(4):532-537. 被引量:12
  • 10LeCluyse EL, Bullock PL and Parkinson A. Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytes [ J]. Adv Drug Delivery Rev, 1996, 22(1 -2) : 133 - 186. 被引量:1

二级参考文献98

  • 1Kang L, Chung BG, Langer R, et al. Microfluidics for drug discovery and development: From target selection to product lifecycle management. Drug Discovery Today, 2008, 12(1/2): 1-13. 被引量:1
  • 2Dittrich PS, Manz A. Lab-on-a-chip: Microfluidics in drug discovery. Nat Rev Drug Discov, 2006, 5:210-218. 被引量:1
  • 3King KR, Wang S, Irimia D, et al. A high-throughput microfluidic real-time gene expression living cell array. Lab Chip, 2007, 7: 77-85. 被引量:1
  • 4Lee PJ, Hung PJ, Rao VM, et al. Nanoliter scale microbioreactor array for quantitative cell biology. Biotech Bioeng, 2006, 94( 1 ): 5-14. 被引量:1
  • 5Ye N, Qin JH, Shi WW, et al. Cell-based high content screening using an integrated microfluidic device. Lab Chip, 2007, 7: 1696-1704. 被引量:1
  • 6Thorsen T, Maerkl S J, Quake SR. Microfluidic large-scale integration. Science, 2002, 298(5593): 580-584. 被引量:1
  • 7Wu MH, Huang SB, Cui Z, et al. Development of perfusion-based micro 3-D cell culture platform and its application for high throughput drug testing. Sens Actuat B 2008, 129(1): 231-240. 被引量:1
  • 8Huang C, Lee G. A microfluidic system for automatic cell culture. J Micromech Microeng, 2007, 17(7): 1266-1274. 被引量:1
  • 9Jeon NL, Dertinger SKW, Chiu DT, et al. Generation of solution and surface gradients using microfluidic systems. Langmuir, 2000, 16(22): 8311-8316. 被引量:1
  • 10杨才表,赵建龙.基于ADμC812的芯片温度控制系统的研究[J].微计算机信息,2007(25):43-44. 被引量:4

共引文献27

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部